λ©ν λλ―Ό
λ©ν λλ―Ό(ν₯μ¬λ―Όμ΄λΌκ³ λ ν¨)μ μ£Όλ‘ μ¬λ°μ± νλΆ μλ‘ κ°μΌμ μλ°© λ° μ₯κΈ° κ΄λ¦¬μ μ¬μ©λλ μλ‘ λ°©λΆμ μ λλ€. **μμ ν:** μ ν΅μ μΈ νμμ κ° μλλΌ μ ꡬμ½λ¬Όλ‘ μμ©ν©λλ€. μ΄ μ½μ ν¨λ₯μ μ°μ± νκ²½μμ ν¬λ¦μλ°νλλ‘ μ νλλ κ²μ μ μ μΌλ‘ μμ‘΄νλ―λ‘ μμΉΌλ¦¬μ± μλ³μ΄λ μ μ κ°μΌμλ ν¨κ³Όκ° μμ΅λλ€. μΈκ· μ ν¬λ¦μλ°νλμ λν΄ μμ°μ μΌλ‘ λ΄μ±μ κ°μ§ μμΌλ―λ‘ λ§μ± κ΄λ¦¬μ μ μ©ν©λλ€.
μμ© κΈ°μ : Methenamine is a prodrug that is hydrolyzed in an acidic environment (urine pH < 5.5) β **ammonia** and **formaldehyde**. Formaldehyde acts as a non-specific bactericidal agent that denatures bacterial proteins and nucleic acids. It requires sufficient time in the bladder to convert and exert its effects.
ν¬μ¬ κ²½λ‘
κΈκΈ°
- Renal insufficiency (can exacerbate systemic acidosis)
- Severe hepatic disease (due to ammonia production)
- Severe dehydration
- Metabolic acidosis
- Concurrent use of sulfonamides
μ΄μλ°μ
- Gastrointestinal upset (nausea, vomiting, diarrhea)
- Dysuria or pollakiuria (due to formaldehyde irritation)
- Hematuria
- Crystalluria (at high doses)
μ½λ¬Ό μνΈμμ©
- Sulfonamides Β· Formaldehyde forms an insoluble precipitate with sulfonamides, increasing the risk of crystalluria and renal damage. Β· major
- Urinary alkalinizers (e.g., Potassium citrate, Sodium bicarbonate) Β· Raises urine pH, preventing the conversion of methenamine to its active form (formaldehyde). Β· major
- Thiazide diuretics Β· May increase urine pH and promote diuresis, reducing formaldehyde concentration and contact time in the bladder. Β· moderate
λͺ¨λν°λ§
- Urine pH (target < 5.5)
- Urinalysis (monitor for crystalluria or hematuria)
- Renal function
- Hepatic function (in prolonged use)
κ³Όμ©λ
Overdosage primarily manifests as severe gastrointestinal distress (vomiting, diarrhea) and urinary tract irritation (hematuria, dysuria, crystalluria). Treatment is supportive and symptomatic. Alkalinizing the urine can halt further conversion to formaldehyde and reduce urinary irritation.
VetSheet μ½λ¬Ό λ νΌλ°μ€λ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μμ¬κ²°μ 보쑰 λꡬμ΄λ©°, μ λ¬Έμ νλ¨μ΄λ μ μ‘°μ¬μ μ΅μ λΌλ²¨μ λμ νμ§ μμ΅λλ€.